In LASCPC-01 cells, higher expression levels of genes encoding SHMT1 and SHMT2 and decreased availability of serine and glycine has been observed, indicating a higher demand of serine and glycine for multiple purposes in this aggressive subtype of prostate cancer. This evidence concerns the gene SHMT1 and prostate carcinoma.